NUNZ - Nunzia Pharmaceutical Company

Other OTC - Other OTC Delayed Price. Currency in USD
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 4/13/2023
Current
9/30/20226/30/20223/31/2022
Market Cap (intraday)
21.73M282.43M301.71M152.81M
Enterprise Value
21.87M282.57M301.85M152.81M
Trailing P/E
N/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/A
Price/Sales (ttm)
N/AN/AN/AN/A
Price/Book (mrq)
N/AN/AN/AN/A
Enterprise Value/Revenue
N/AN/AN/AN/A
Enterprise Value/EBITDA
-0.23-1.24k-15.02k-8.16

Yahoo Finance Plus Essential access required.

Learn more

Trading Information

Stock Price History

Beta (5Y Monthly) -1.89
52-Week Change 3-89.98%
S&P500 52-Week Change 32.74%
52 Week High 30.7000
52 Week Low 30.0446
50-Day Moving Average 30.0486
200-Day Moving Average 30.2485

Share Statistics

Avg Vol (3 month) 31.45k
Avg Vol (10 day) 3152
Shares Outstanding 5434.52M
Implied Shares Outstanding 6N/A
Float 878.36M
% Held by Insiders 181.96%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Dec 03, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:7000
Last Split Date 3Dec 03, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Sep 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-270,239.14%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-96.99M
Diluted EPS (ttm)-0.3000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)35.37k
Total Cash Per Share (mrq)0
Total Debt (mrq)183.34k
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.16
Book Value Per Share (mrq)-0.00

Cash Flow Statement

Operating Cash Flow (ttm)-202k
Levered Free Cash Flow (ttm)36.09M